<SEC-DOCUMENT>0001213900-21-008855.txt : 20210212
<SEC-HEADER>0001213900-21-008855.hdr.sgml : 20210212
<ACCEPTANCE-DATETIME>20210212143022
ACCESSION NUMBER:		0001213900-21-008855
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20210212
FILED AS OF DATE:		20210212
DATE AS OF CHANGE:		20210212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SOS Ltd
		CENTRAL INDEX KEY:			0001346610
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38051
		FILM NUMBER:		21625818

	BUSINESS ADDRESS:	
		STREET 1:		ROOM 8888, JIUDINGFENG BUILDING,
		STREET 2:		888 CHANGBAISHAN ROAD, QINGDAO AREA
		CITY:			SHANDONG
		STATE:			F4
		ZIP:			200335
		BUSINESS PHONE:		86 0311-80910921

	MAIL ADDRESS:	
		STREET 1:		ATM CAPITAL PARTNERS LLC
		STREET 2:		35 EAST 38TH ST STE 11C
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	China Rapid Finance Ltd
		DATE OF NAME CHANGE:	20150923

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	China Risk Finance LLC
		DATE OF NAME CHANGE:	20051212
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea135490-6k_soslimited.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Form 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16 <BR>
UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For the month of February 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Commission File Number: 001-38051</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SOS Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Translation of registrant&rsquo;s name
into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Room 8888, Jiudingfeng Building, 888 Changbaishan
Road,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Qingdao Area, China (Shandong) Pilot Free
Trade Zone</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">+86 0311-80910921</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Form 20-F&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 9, 2021,
SOS Limited (the &ldquo;<B>Company</B>&rdquo;) entered into a letter agreement (&ldquo;<B>Letter Agreement</B>&rdquo;) with certain
holders of Company&rsquo;s warrants, pursuant to which the holders of Company&rsquo;s warrants exercised all of the Existing Warrants
(as defined below) to purchase up 23,880,000 of the Company&rsquo;s American Depositary Shares (&ldquo;<B>ADSs</B>&rdquo;). The
exercise price of the warrants issued by the Company to certain institutional investors on January 20, 2021 (the &ldquo;<B>Existing
Warrants</B>&rdquo;) was $2.00 per ADS. Pursuant to the Letter Agreement, each holder will receive new warrants (the &ldquo;<B>New
Warrants</B>&rdquo;) to purchase up to 23,880,000 ADSs in exchange for their exercise of all of the Existing Warrants with cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The gross proceeds
to the Company from the exercise of the Existing Warrants was approximately $48 million, prior to deducting placement agent fees
and estimated offering expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The New Warrants will
have substantially the same terms as Existing Warrants, except for (i) registration rights whereby the Company agrees to register
the ADSs underlying the New Warrants within twenty-one (21) days of closing, and (ii) an exercise price $4.05 per ADS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the transactions contemplated in the Letter Agreement, the Company entered into a letter agreement (the &ldquo;<B>Engagement Letter</B>&rdquo;)
with Maxim Group LLC (the &ldquo;<B>Financial Advisor</B>&rdquo;). Pursuant to the terms of the Engagement Letter, the Financial
Advisor is entitled to a cash fee equal to 7.0% of the gross proceeds raised in the transactions contemplated by the Letter Agreement.
The Company also agreed to reimburse the Placement Agent for certain expenses, including for fees and expenses related to legal
expenses limited to $15,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transaction contemplated
by the Letter Agreement closed on February 10, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The issuance of New
Warrants was made in reliance upon an exemption from the registration requirements pursuant to Section 4(a)(2) of the Securities
Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Copies of the form
of the Letter Agreement, form of New Warrant, and the Engagement Letter are attached hereto as Exhibits 99.1, 99.2, and 99.3, respectively.
The foregoing summaries of the terms of the Letter Agreement, New Warrants, and the Engagement Letter are subject to, and qualified
in their entirety by, such documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 9, 2021,
the Company issued a press release announcing the transactions described above. A copy of the press release is attached hereto
as Exhibit 99.4.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Exhibits</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 9%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><B>&nbsp;</B></TD>
    <TD STYLE="vertical-align: bottom; width: 90%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea135490ex99-1_soslimited.htm">Form of the Letter Agreement</A></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea135490ex99-2_soslimited.htm">Form of Warrant</A></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea135490ex99-3_soslimited.htm">Engagement Letter dated February 7, 2021</A></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea135490ex99-4_soslimited.htm">Press Release dated February 9, 2021</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: February 12, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SOS Limited</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Yandai Wang</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yandai Wang</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea135490ex99-1_soslimited.htm
<DESCRIPTION>FORM OF THE LETTER AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SOS Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Room 8888, Jiudingfeng Building, 888 Changbaishan
Road,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Qingdao Area, China (Shandong) Pilot Free
Trade Zone</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">+86 0311-80910921</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">February [&nbsp;&nbsp;&nbsp;], 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holder of American Depositary Shares Purchase
Warrant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Re:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Inducement
Offer to Exercise American Depositary Shares Purchase Warrants</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SOS Limited (the &ldquo;<U>Company</U>&rdquo;)
is pleased to offer to you the opportunity to exercise all of the American Depositary Shares Purchase Warrants issued to certain
investors on January 20, 2021 (&ldquo;<U>Existing Warrants</U>&rdquo;), with exercise price of $2.00, set forth on the signature
page hereto, currently held by you (the &ldquo;<U>Holder</U>&rdquo;). The offer and resale of the Existing Warrants and the American
Depositary Shares (&ldquo;<U>ADSs</U>&rdquo;) underlying the Existing Warrants (&ldquo;<U>Warrant Shares</U>&rdquo;) have been
registered pursuant to registration statement Form F-3 (File No. 333-252279) (the &ldquo;<U>Registration Statement</U>&rdquo;).
The Registration Statement is currently effective and, upon exercise of the Existing Warrants pursuant to this letter agreement,
will be effective for the issuance or sale, as the case may be, of the Warrant Shares. Capitalized terms not otherwise defined
herein shall have the meanings set forth in the Existing Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration for
exercising in full all of the Existing Warrants held by you and set forth on the signature page hereto (the &ldquo;<U>Warrant Exercise</U>&rdquo;),
the Company hereby offers to issue you or your designee,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the Existing Warrants exercised hereunder, a new series ADSs Purchase Warrants (&ldquo;<U>New Warrants</U>&rdquo;) pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (&ldquo;<U>Securities Act</U>&rdquo;) to purchase a quantity of &nbsp;ADS equal to&nbsp;100%&nbsp;of the number of Warrant Shares issued pursuant to the exercise of the Existing Warrants hereunder, which New Warrants shall be substantially in the form of the Existing Warrants, will be exercisable immediately with an expiration date on February 10, 2026, and an exercise price equal to&nbsp;$4.05.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The original New Warrant
certificates will be delivered within two Business Days following the date hereof. Notwithstanding anything herein to the contrary,
in the event the exercise of Warrant would otherwise cause the Holder to exceed the beneficial ownership limitations (&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo;) set forth in Section 2(e) of the Existing Warrants, the Company shall only issue such number of
Warrant Shares to the Holder that would not cause the Holder to exceed the maximum number of Warrant Shares permitted thereunder
with the balance to be held in abeyance until notice from the Holder that the balance (or portion thereof) may be issued in compliance
with such limitations, which abeyance shall be evidenced through the Existing Warrants which shall be deemed prepaid thereafter,
and exercised pursuant to a Notice of Exercise in the Existing Warrant (provided no additional exercise shall be payable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Expressly subject to the paragraph immediately
following this paragraph below, Holder may accept this offer by signing this letter below, with such acceptance constituting Holder&rsquo;s
exercise in full of the Existing Warrants for an aggregate exercise price set forth on the Holder&rsquo;s signature page hereto
(the &ldquo;<U>Warrants Exercise Price</U>&rdquo;) on or before 9:00 a.m. Eastern on February 9, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the Company
agrees to the representations, warranties and covenants set forth on&nbsp;<U>Annex A</U>&nbsp;attached hereto. Holder represents
and warrants that it is an &ldquo;accredited investor&rdquo; as defined in Rule 501 of the Securities Act, and agrees that the
New Warrants will contain restrictive legends when issued, and neither the New Warrants nor the ADSs issuable upon exercise of
the New Warrants will be registered under the Securities Act, except in the discretion of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Holder understands
that the New Warrants and the ADSs underlying New Warrants are not, and may never be, registered under the Securities Act, or the
securities laws of any state and, accordingly, each certificate, if any, representing such securities shall bear a legend substantially
similar to the following:&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&ldquo;THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED
BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a)
UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certificates evidencing
ADSs underlying the New Warrants shall not contain any legend (including the legend set forth above), (i) while a registration
statement covering the resale of such ADSs is effective under the Securities Act, (ii) following any sale of such ADSs pursuant
to Rule 144 under the Securities Act, (iii) if such ADSs is eligible for sale under Rule 144, without the requirement for the Company
to be in compliance with the current public information required under Rule 144 as to such ADSs and without volume or manner-of-sale
restrictions, (iv)&nbsp;if such ADSs may be sold under Rule 144 and the Company is then in compliance with the current public information
required under Rule 144 as to such ADSs, or (v) if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
and the earliest of clauses (i) through (v), the &ldquo;<U>Delegend Date</U>&rdquo;)). The Company shall cause its counsel to issue
a legal opinion to the transfer agent promptly after the Delegend Date if required by the Company and/or the transfer agent to
effect the removal of the legend hereunder, which opinion shall be in form and substance reasonably acceptable to the Holder. If
such ADSs may be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information
required under Rule 144 or if such legend is not otherwise required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the staff of the Commission) then such Common Stock shall be issued free
of all legends. The Company agrees that following the Delegend Date or at such time as such legend is no longer required under
this Section 2.3(b), it will, no later than two (2) Trading Days following the delivery by the Holder to the Company or the transfer
agent of a certificate representing the Common Stock underlying the New Warrants issued with a restrictive legend (such second
Trading Day, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to the Holder a certificate representing
such shares that is free from all restrictive and other legends or, at the request of the Holder shall credit the account of the
Holder&rsquo;s prime broker with the Depository Trust Company System as directed by the Holder. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to
the Holder&rsquo;s other available remedies, the Company shall pay to a Holder, in cash, (i) as partial liquidated damages and
not as a penalty, for each $1,000 of ADSs or Warrant Shares (based on the VWAP of the ADSs on the date such Warrant Shares are
submitted to the Transfer Agent) delivered for removal of the restrictive legend, $10 per Trading Day (increasing to $20 per Trading
Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date until such
certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered) to
the Holder by the Legend Removal Date a certificate representing the Securities so delivered to the Company by the Holder that
is free from all restrictive and other legends and (b) if after the Legend Removal Date the Holder purchases (in an open market
transaction or otherwise) ADSs to deliver in satisfaction of a sale by the Holder of all or any portion of the number of ADSs,
or a sale of a number of ADSs equal to all or any portion of the number of ADSs that the Holder anticipated receiving from the
Company without any restrictive legend, then, an amount equal to the excess of the Holder&rsquo;s total purchase price (including
brokerage commissions and other out-of-pocket expenses, if any) for the ADSs so purchased (including brokerage commissions and
other out-of-pocket expenses, if any) (the &ldquo;<B><U>Buy-In Price</U></B>&rdquo;) over the product of (A) such number of Warrant
Shares that the Company was required to deliver to the Holder by the Legend Removal Date multiplied by (B) the lowest closing sale
price of the ADSs on any Trading Day during the period commencing on the date of the delivery by the Holder to the Company of the
applicable Warrant Shares (as the case may be) and ending on the date of such delivery and payment under this clause (ii). &nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time during
the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the New Warrant
Shares may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction
or limitation pursuant to Rule 144, if there is no effective registration statement covering the resale of all of the New Warrant
Shares and the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c) or
(ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy
any condition set forth in Rule 144(i)(2) (a &ldquo;Public Information Failure&rdquo;) then, in addition to the undersigned&rsquo;s
other available remedies, the Company shall pay to the undersigned, in cash, as partial liquidated damages and not as a penalty,
by reason of any such delay in or reduction of its ability to sell the New Warrant Shares, an amount in cash equal to two percent
(2.0%) of the aggregate Exercise Price of the undersigned&rsquo;s New Warrant on the day of a Public Information Failure and on
every thirtieth (30th) day (pro-rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date
such Public Information Failure is cured and (b) such time that such public information is no longer required for the undersigned
to transfer the New Warrant Shares pursuant to Rule 144. The payments to which the undersigned shall be entitled pursuant to this
Section (g) are referred to herein as &ldquo;Public Information Failure Payments.&rdquo; Public Information Failure Payments shall
be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred
and (ii) the third (3rd) Business Day after the event or failure giving rise to the Public Information Failure Payments is cured.
In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure
Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall
limit the undersigned&rsquo;s right to pursue actual damages for the Public Information Failure, and the undersigned shall have
the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From the date hereof
until the end of the 30 Trading Day following the date of the filing of the Resale Registration Statement (defined hereinafter),
neither the Company nor any subsidiary of the Company (the Company acknowledging that it does not currently have any subsidiaries)
shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any ADSs or any securities
of the Company or any subsidiaries which would entitle the holder thereof to acquire at any time ADSs, including, without limitation,
any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable
for, or otherwise entitles the holder thereof to receive, ADSs, or (ii) file any registration statement, or amendment or supplement
thereto, with the Commission other than those filed pursuant to this agreement, Other Warrant Exercise Agreements or substantially
similar agreements related to similar inducement offers regarding other warrants outstanding on the date hereof. Notwithstanding
the foregoing, the foregoing shall not apply in respect of an Exempt Issuance. &ldquo;Exempt Issuance&rdquo; means the issuance
of (a) ADSs, Ordinary Shares or options to employees, officers or directors of the Company pursuant to any stock or option plan
duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members
of a committee of non-employee directors established for such purpose for services rendered to the Company, provided, however,
such issuance shall not exceed ten percent (10%) of the ADSs or Ordinary Shares issued and outstanding as of the date hereof, (b)
the offer and issuance of New Warrants to Other Holders (defined below) and (c) securities issued pursuant to acquisitions or strategic
transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as
&ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing
of any registration statement in connection therewith, and provided that any such issuance shall only be to a Person (or to the
equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business
synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment
of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital
or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this offer is accepted
and the transaction documents are executed on or before 9:00 a.m. ET on February 9, 2021, then on or before 9:30 a.m. ET on the
same Trading Day, the Company shall issue a press release disclosing all material terms of the transactions contemplated hereunder.
From and after the issuance of such press release, the Company represents to you that it shall have publicly disclosed all material,
non-public information delivered to you by the Company, or any of their respective officers, directors, employees or agents in
connection with the transactions contemplated hereunder. In addition, effective upon the issuance of such press release, the Company
acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between
the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one
hand, and you and your Affiliates on the other hand, shall terminate. The Company represents, warrants and covenants that, upon
acceptance of this offer, the shares underlying the Existing Warrants shall be issued free of any legends or restrictions on resale
by Holder and all of the Warrant Shares shall be delivered electronically through the Depository Trust Company within 2 Business
Day of the date the Company receives the Warrants Exercise Price (or, with respect to Warrant Shares that would otherwise be in
excess of the Beneficial Ownership Limitation, within 2 Business Days of the date the Company is notified by Holder that its ownership
is less than the Beneficial Ownership Limitation). The terms of the Existing Warrants, including but not limited to the obligations
to deliver the Warrant Shares, shall otherwise remain in effect as if the acceptance of this offer were a formal Notice of Exercise
(including but not limited to any liquidated damages and compensation in the event of late delivery of the Warrant Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As soon as practicable
(and in any event within twenty one (21) calendar days of the date of this letter agreement), the Company shall file a registration
statement (the &ldquo;<U>Resale Registration Statement</U>&rdquo;)on Form F-3 (or other appropriate form if the Company is not
then F-3 eligible) providing for the resale by the Purchasers of the New Warrant Shares issued and issuable upon exercise of the
New Warrants.&nbsp; The Company shall use commercially reasonable efforts to cause such registration to become effective within
90 days following the Closing Date and to keep such registration statement effective at all times until no Purchaser owns any New
Warrants or New Warrant Shares issuable upon exercise thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that the obligations of the Holders under this letter agreement are several and not joint with the obligations of any
other holder or any other holders of Warrants to Purchase ADSs of the Company (each, an &ldquo;<U>Other Holder</U>&rdquo;) under
any other agreement related to the exercise of such warrants (&ldquo;<U>Other Warrant Exercise Agreement</U>&rdquo;), and the Holder
shall not be responsible in any way for the performance of the obligations of any Other Holder or under any such Other Warrant
Exercise Agreement. Nothing contained in this letter agreement, and no action taken by the Holders pursuant hereto, shall be deemed
to constitute the Holder and the Other Holders as a partnership, an association, a joint venture or any other kind of entity, or
create a presumption that the Holder and the Other Holders are in any way acting in concert or as a group with respect to such
obligations or the transactions contemplated by this letter agreement and the Company acknowledges that the Holder and the Other
Holders are not acting in concert or as a group with respect to such obligations or the transactions contemplated by this letter
agreement or any Other Warrant Exercise Agreement. The Company and the Holder confirm that the Holder has independently participated
in the negotiation of the transactions contemplated hereby with the advice of its own counsel and advisors. The Holder shall be
entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this letter
agreement, and it shall not be necessary for any Other Holder to be joined as an additional party in any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby
represents and warrants as of the date hereof and covenants and agrees from and after the date hereof until 30 Trading Days after
the date hereof, that none of the terms offered to any Other Holder with respect to any Other Warrant Exercise Agreement (or any
amendment, modification or waiver thereof), is or will be more favorable to such Other Holder than those of the Holder and this
letter agreement. If, and whenever on or after the date hereof until 30 Trading Days after the date hereof, the Company enters
into an Other Warrant Exercise Agreement, then (i) the Company shall provide notice thereof to the Holder promptly following the
occurrence thereof and (ii) the terms and conditions of this letter agreement shall be, without any further action by the Holder
or the Company, automatically amended and modified in an economically and legally equivalent manner such that the Holder shall
receive the benefit of the more favorable terms and/or conditions (as the case may be) set forth in such Other Warrant Exercise
Agreement (including the issuance of additional Warrant Shares), provided that upon written notice to the Company at any time the
Holder may elect not to accept the benefit of any such amended or modified term or condition, in which event the term or condition
contained in this letter agreement shall apply to the Holder as it was in effect immediately prior to such amendment or modification
as if such amendment or modification never occurred with respect to the Holder. The provisions of this paragraph shall apply similarly
and equally to each Other Warrant Exercise Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">***************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Within one business day from the Holder&rsquo;s execution of
this letter, the Holder shall make available for &ldquo;Delivery Versus Payment&rdquo; to the Company immediately available funds
equal to the number of Existing Warrants being exercised multiplied by&nbsp;<B>$2.00</B>&nbsp;and the Company shall deliver the
Warrant Shares via &ldquo;Delivery Versus Payment&rdquo; to the Holder and shall deliver the New Warrants registered in the name
of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please do not hesitate
to call me if you have any questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely yours,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SOS Limited</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 60%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yandai Wang</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accepted and Agreed to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 59%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Holder:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 41%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized Signatory of Holder</I>:</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory:</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory:</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New Warrants: (100% of total Existing Warrants being exercised):&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC Instructions:</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Representations,
Warranties and Covenants of the Company</U>. The Company hereby makes the following representations and warranties to the Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Affirmation
of Prior Representations, Warranties and Covenants</U>. The Company hereby represents and warrants to the Holder that the Company&rsquo;s
representations and warranties as set forth in Section 3.1 of that certain securities purchase agreement, dated January 7, 2021,
between the Company and each purchaser identified on the signature pages thereto (the &ldquo;<U>Purchase Agreement</U>&rdquo;),
together with any updates in the Company&rsquo;s public reports filed with the SEC subsequent to the Purchase Agreement, are true
and correct as of the date hereof and have been fully performed as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this letter agreement and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this
letter agreement by the Company and the consummation by the Company of the transactions contemplated hereby have been duly authorized
by all necessary action on the part of the Company and no further action is required by the Company, its board of directors or
its stockholders in connection therewith. This letter agreement has been duly executed by the Company and, when delivered in accordance
with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>No
Conflicts</U>. The execution, delivery and performance of this letter agreement by the Company and the consummation by the Company
of the transactions contemplated hereby do not and will not: (i) conflict with or violate any provision of the Company&rsquo;s
certificate or articles of incorporation, bylaws or other organizational or charter documents; or (ii) conflict with, or constitute
a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any &nbsp;liens,
claims, security interests, other encumbrances or defects upon any of the properties or assets of the Company in connection with,
or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or
both) of, any material agreement, credit facility, debt or other material instrument (evidencing Company debt or otherwise) or
other material understanding to which such Company is a party or by which any property or asset of the Company is bound or affected;
or (iii) conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction
of any court or governmental authority to which the Company is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company is bound or affected, except, in the case of each of clauses (ii) and (iii), such
as could not have or reasonably be expected to result in a material adverse effect upon the business, prospects, properties, operations,
condition (financial or otherwise) or results of operations of the Company, taken as a whole, or in its ability to perform its
obligations under this letter agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>NYSE
Corporate Governance</U>. The transactions contemplated under this letter agreement, comply with all rules of the NYSE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) Registration
Statement. The Warrant Shares are registered for issuance on a Registration Statement on Form F-3 (File No. 333-252279) (the &ldquo;Registration
Statement&rdquo;) and the Company knows of no reason why such registration statement shall not remain effective for the foreseeable
future. The Company shall use commercially reasonable efforts to keep the Registration Statement effective and available for use
by the Holder until all Warrant Shares underlying the Existing Warrants are sold by the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) Issuance
of the New Warrant. The issuance of the New Warrants is duly authorized and, upon the execution of this letter agreement by the
undersigned, will be duly and validly issued, fully paid and nonassessable, free and clear of all liens imposed by the Company,
and the shares issuable upon exercise of the New Warrant (the &ldquo;New Warrant Shares&rdquo;), when issued in accordance with
the terms of the New Warrant, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the
Company. The Company has reserved from its duly authorized capital stock a number of shares of Common Stock for issuance of the
New Warrant Shares in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) Listing
of Common Stock. The Company shall apply to list or quote all of the New Warrant Shares on NYSE and promptly secure the listing
of all of the New Warrant Shares on NYSE.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">7</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ea135490ex99-2_soslimited.htm
<DESCRIPTION>FORM OF WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 99.2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE
UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WARRANT TO PURCHASE AMERICAN DEPOSITARY
SHARES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SOS LIMITED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; font-size: 10pt">Warrant Shares: [_______]</TD>
    <TD STYLE="width: 49%; font-size: 10pt; text-align: right">Issue Date: February [&nbsp;&nbsp;&nbsp;], 2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS WARRANT TO PURCHASE
AMERICAN DEPOSITARY SHARES (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after February 10, 2021 and on or prior to 5:00 p.m. (New York City time) on February 10, 2026 (the
&ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from SOS Limited., a Cayman Islands company
(the &ldquo;<U>Company</U>&rdquo;), up to _____________American Depositary Shares (each, an &ldquo;ADS&rdquo; and, collectively,
the &ldquo;ADSs&rdquo;), each ADS representing ten Class A Ordinary Shares par value US$0.0001 per share of the Company (&ldquo;<U>Ordinary
Shares</U>&rdquo;). The purchase price of one ADS shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreements
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated December 22, 2020, and January 7, 2021, among the Company and the purchasers
signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant. </U>Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or a PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;Notice
of Exercise&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard
Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the
applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other
type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the
Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant
Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to
the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the
Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to
the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1)
Business Day of receipt of such notice.&nbsp;<B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) Exercise
Price. The exercise price per ADS under this Warrant shall be&nbsp;US4.05, subject to adjustment hereunder (the &ldquo;Exercise
Price&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) Cashless
Exercise. If at any time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for, the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt">(A) =</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the Bid Price on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt">(B) =</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt">(X) =</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9)
of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The
Company agrees not to take any position contrary to this Section 2(c). Without limiting the cashless exercise provision set forth
in this Section 2(c), the liquidated damages provision in Section 2(d)(i) or the buy-in provision in Section 2(d)(iv), there is
no circumstance that would require the Company to net-cash settle this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the ADSs are then listed or
quoted on a Trading Market, the bid price of the ADSs for the time in question (or the nearest preceding date) on the Trading Market
on which the ADSs are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the ADSs for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the ADSs are not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the ADSs are then reported on the Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per ADS so reported, or (d)&nbsp;in all other
cases, the fair market value of one ADS as determined by an independent appraiser selected in good faith by the Purchasers of a
majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which
shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the ADSs are then listed or
quoted on a Trading Market, the daily volume weighted average price of the ADSs for such date (or the nearest preceding date) on
the Trading Market on which the ADSs are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the ADSs for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the ADSs are not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the ADSs are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per ADS so reported,
or (d)&nbsp;in all other cases, the fair market value of one ADS as determined by an independent appraiser selected in good faith
by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything
herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to
this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Mechanics
of Exercise.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall deposit the Ordinary Shares represented by the Warrant Shares with the Depositary
and shall instruct the Depositary to transmit the Warrant Shares purchased hereunder to the Holder by crediting the account of
the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal
at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an
effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder
or (B) the Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate registered in
the ADS register maintained by the Depositary, the name of the Holder or its designee as the holder of the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise and physical delivery of a certificate in respect of such Warrant Shares
to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after
the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price
to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company
of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;), provided, however in the event such
date falls on a public holiday in the Hong Kong Special Administrative Region (&ldquo;<B>Hong Kong</B>&rdquo;), such date shall
be the next Trading Day that is not a public holiday in Hong Kong. Upon the delivery of the Notice of Exercise, the Holder shall
be deemed for purposes of Regulation SHO to have become the holder of record of the Warrant Shares with respect to which this Warrant
has been exercised, irrespective of the date of delivery of the Warrant Shares,&nbsp;<I>provided that</I>&nbsp;payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii)
the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company
fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares
subject to such exercise (based on the VWAP of the Ordinary Shares on the date of the applicable Notice of Exercise), $10 per Trading
Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company
agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.
As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of
Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Ordinary Shares as in effect on the date of delivery
of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Depositary to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder,
if the Company fails to cause the Depositary to transmit to the Holder the Warrant Shares in accordance with the provisions of
Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is
required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise
purchases, Ordinary Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated
receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount,
if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the Ordinary Shares
so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver
to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase
obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number
of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to
the Holder the number of Ordinary Shares that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases Ordinary Shares having a total purchase price of $11,000 to cover a
Buy-In with respect to an attempted exercise of Ordinary Shares with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The
Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon
request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other
remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver Ordinary Shares upon exercise of the Warrant as
required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or
other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require,
as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall
pay all Depositary fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant
Shares, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">vii. <U>Closing
of Books</U>. The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this
Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;Attribution Parties&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing
sentence, the number of ADSs or Ordinary Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall
include the number of ADSs and underlying Ordinary Shares issuable upon exercise of this Warrant with respect to which such determination
is being made, but shall exclude the number of ADSs and underlying Ordinary Shares which would be issuable upon (i) exercise of
the remaining, non-exercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties
and (ii) exercise or conversion of the unexercised or non-converted portion of any other securities of the Company (including,
without limitation, any other Ordinary Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation
contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in
the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section
13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company
is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained
in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by
the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in
the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and
the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to
any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding ADSs and/or Ordinary
Shares, a Holder may rely on the number of outstanding ADSs and/or Ordinary Shares as reflected in (A) the Company&rsquo;s most
recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company
or (C) a more recent written notice by the Company or the Depositary setting forth the number of ADSs outstanding.&nbsp; Upon the
written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number
of ADSs and/or Ordinary Shares then outstanding.&nbsp; In any case, the number of outstanding ADSs and/or Ordinary Shares shall
be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder
or its Affiliates or Attribution Parties since the date as of which such number of outstanding ADSs and/or Ordinary Shares was
reported. The &ldquo;Beneficial Ownership Limitation&rdquo; shall be 4.99% of the number of ADSs and/or Ordinary Shares outstanding
immediately after giving effect to the issuance of ADSs and underlying Ordinary Shares issuable upon exercise of this Warrant.
The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section
2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of ADSs and/or Ordinary Shares
outstanding immediately after giving effect to the issuance of ADSs and underlying Ordinary Shares upon exercise of this Warrant
held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP>&nbsp;day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e)
to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.
The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Mandatory
Exercise. </U>If at any time from and after the date hereof, the closing price of the Company&rsquo;s ADSs on the Trading Market
equals or exceeds 300% of the initial Exercise Price (which is subject to adjustment for reverse and forward stock splits, stock
dividends, stock combinations and other similar transactions of the ADSs that occur after the Issue Date of this Warrant) for ten
(10) consecutive Trading Days (the &ldquo;Mandatory Exercise Measuring Period&rdquo;), then the Company shall have the right to
require the Holder to exercise all or any portion of this Warrant still unexercised for a cash exercise, as designated in the Mandatory
Exercise Notice on the Mandatory Exercise Date (each as defined below) into Warrant Shares in accordance with Section 2 hereof
at the Exercise Price (subject to adjustment as set forth in this Warrant) as of the Mandatory Exercise Date (as defined below)
(a &ldquo;Mandatory Exercise&rdquo;). The Company may exercise its right to require exercise under this Section 2(f) by delivering
within not more than five (5) Trading Days following the last Trading Day of the Mandatory Exercise Measuring Period, a written
notice thereof by electronic mail to the Holder (the &ldquo;Mandatory Exercise Notice&rdquo; and the date that the Holder received
such notice is referred to as the &ldquo;Mandatory Exercise Notice Date&rdquo;). Subject to the conditions described below in this
Section 2(f), the Mandatory Exercise Notice shall be irrevocable. The Mandatory Exercise Notice shall state (I) the Trading Day
on which the Mandatory Exercise shall occur, which shall be the second (2nd) Trading Day following the Mandatory Exercise Notice
Date (the &ldquo;Mandatory Exercise Date&rdquo;) and (II) the aggregate number of Warrant Shares which the Company has elected
to be subject to such Mandatory Exercise (the &ldquo;Mandatory Exercise Amount&rdquo;) pursuant to this Section 2(f). Notwithstanding
anything to the contrary contained in this Section 2(f), the Company may only exercise its rights under this Section 2(f) if (i)the
ADSs are trading on a Trading Market and all of the shares issuable pursuant to the Transaction Documents are listed or, if required,
quoted for trading on such Trading Market (and the Company believes, in good faith, that trading of the ADSs on a Trading Market
will continue uninterrupted for the then-foreseeable future), (ii) the issuance of the Warrant Shares to the Holder pursuant to
this Section 2(f) to the Holder does not violate the limitations set forth in Section 2(e) of this Warrant or any the NYSE Rules
and Regulations, (iii) the Holder is not in possession of any information provided by the Company, any of its Subsidiaries, or
any of their officers, directors, employees, agents, or Affiliates, that constitutes, or may reasonably be deemed to constitute,
material non-public information, (iv) for each Trading Day in a period of twenty (20) consecutive Trading Days prior to the Mandatory
Exercise Date, the daily trading volume for the ADSs on the Trading Market exceeds 300,000 ADSs per Trading Day subject to adjustment
for forward and reverse stock splits and the like) and (v) there is effective registration statement registering, the resale of
the Warrant Shares by the Holder. Prior to the issuance of any Warrant Shares in connection with a Mandatory Exercise on a Mandatory
Exercise Date, the Holder shall have the right to continue to exercise this Warrant in accordance with terms of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on its ADSs or Ordinary Shares or any other equity or equity equivalent securities payable
in ADSs or Ordinary Shares (which, for avoidance of doubt, shall not include any ADSs and underlying Ordinary Shares issued by
the Company upon exercise of this Warrant), (ii) subdivides outstanding ADSs or Ordinary Shares into a larger number of ADSs or
shares, (iii) combines (including by way of reverse stock split) outstanding ADSs or Ordinary Shares into a smaller number of ADSs
or shares or (iv) issues by reclassification of ADSs or Ordinary Shares any capital shares of the Company, then in each case the
Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of ADSs or Ordinary Shares, as applicable
(excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number
of ADSs or Ordinary Shares, as applicable outstanding immediately after such event, and the number of shares issuable upon exercise
of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.
Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination
of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date
in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Intentionally
Omitted.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues
or sells any Ordinary Share Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of ADSs or Ordinary Shares (the &ldquo;Purchase Rights&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder
had held the number of ADSs or Ordinary Shares acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record
is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record
holders of ADSs or Ordinary Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided,&nbsp;however,
that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such ADSs or Ordinary Shares as a result of such Purchase Right to such extent) and such Purchase Right
to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the
Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to holders of ADSs or Ordinary Shares, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of
a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;Distribution&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of ADSs or Ordinary Shares
acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such
record is taken, the date as of which the record holders of ADSs or Ordinary Shares are to be determined for the participation
in such Distribution (provided,&nbsp;however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution
would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate
in such Distribution to such extent (or in the beneficial ownership of any ADSs or Ordinary Shares as a result of such Distribution
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if
ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this
Warrant has not been partially or completely exercised at the time of such Distribution, such portion of the Distribution shall
be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 9.5pt">e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of ADSs and/or Ordinary Shares are permitted
to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of fifty
percent (50%) or more of the voting power, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the ADSs or Ordinary Shares or any compulsory share exchange pursuant
to which the Ordinary Shares are effectively converted into or exchanged for other securities, cash or property, or (v) the Company,
directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires more than fifty percent (50%) of the voting power
(not including any voting power held by the other Person or other Persons making or party to, or associated or affiliated with
the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;Fundamental
Transaction&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each
Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction,
at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of
ADSs and/or Ordinary Shares of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and
any additional consideration (the &ldquo;Alternate Consideration&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of Ordinary Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate
Consideration issuable in respect of one ADS or one Ordinary Share, as applicable, in such Fundamental Transaction, and the Company
shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of ADSs and/or Ordinary Shares are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to
the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding
anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall,
at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant
from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining
unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction;&nbsp;provided,&nbsp;however,
if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board
of Directors, Holder shall only be entitled to receive from the Company or any Successor Entity, the same type or form of consideration
(and in the same proportion), at the Black Scholes Value (as defined below) of the unexercised portion of this Warrant, that is
being offered and paid to the holders of ADSs or Ordinary Shares, as applicable, in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of ADSs or Ordinary
Shares, as applicable, are given the choice to receive from among alternative forms of consideration in connection with the Fundamental
Transaction; provided, further, that if holders of ADSs and/or Ordinary Shares of the Company are not offered or paid any consideration
in such Fundamental Transaction, such holders of ADSs and/or Ordinary Shares shall be deemed to have received ordinary shares
or common stock of the Successor Entity (which entity may be the Company following such Fundamental Transaction) in such Fundamental
Transaction. &ldquo;Black Scholes Value&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model
obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;Bloomberg&rdquo;) determined as of the day of consummation
of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the
U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained
from the &ldquo;HVT&rdquo; function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately
following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used
in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of
any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater of (x) the last VWAP immediately
prior to the public announcement of such contemplated Fundamental Transaction and (y) the last VWAP immediately prior to the consummation
of such Fundamental Transaction, (D) a remaining option time equal to the time between the date of the public announcement of
the applicable contemplated Fundamental Transaction and the Termination Date, and (E) a zero cost of borrow. The payment of the
Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within five Business
Days of the Holder&rsquo;s election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause
any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;Successor Entity&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder
and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the
Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the ADSs and/or Ordinary Shares acquirable and receivable
upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the ADSs or Ordinary Shares, as applicable, pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the
economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably
satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity
shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this
Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant
and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section 3, the number of ADSs and/or Ordinary Shares deemed to be issued and outstanding as of a given date
shall be the sum of the number of ADSs or Ordinary Shares, as applicable (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice
to Holder.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify; text-indent: 27pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
ADSs and/or Ordinary Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the ADSs
and/or Ordinary Shares, (C) the Company shall authorize the granting to all holders of the ADSs and/or Ordinary Shares rights or
warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any shareholders
of the Company shall be required in connection with any reclassification of the ADSs and/or Ordinary Shares, any consolidation
or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any
compulsory share exchange whereby the ADSs and/or Ordinary Shares are converted into other securities, cash or property, or (E)
the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company,
then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or
email address as it shall appear upon the Warrant Register of the Company, at least twenty (20) calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
of the ADSs and/or Ordinary Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are
to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the ADSs and/or Ordinary Shares of record
shall be entitled to exchange their ADSs and/or Ordinary Shares for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein
or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the
extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company
or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report of Foreign
Private Issuer on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date
of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in
part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment
of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company
shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion
of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary
and subject to Sections 2(a) and 2(d)(ii), the Holder shall not be required to physically surrender this Warrant to the Company
unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within
three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.
The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants
to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original
Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;Warrant
Register&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for
all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Shareholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i). Notwithstanding the foregoing, prior
to the exercise of the Warrant, the Holder shall have all the rights as a Holder of the Warrant, including, without limitation,
as set forth in Section 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of
the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate,
if mutilated, the Company will make and deliver a new Warrant or share certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or share certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company
covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued ADSs and Ordinary
Shares a sufficient number of ADSs and shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its
officers who are charged with the duty of completing the issuance of the necessary Warrant Shares upon the exercise of the purchase
rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market
upon which the ADSs may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase
rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such
Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and non-assessable and free from all taxes,
liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring
contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and
to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its memorandum of association and articles of association or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking
of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.
Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the
amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be
necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon
the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents
from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations
under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does
not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Non-waiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to
cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder
for the purchase price of any ADS or Ordinary Share or as a shareholder of the Company, whether such liability is asserted by the
Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert
the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure
to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of the Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant
and shall be enforceable by the Holder or a holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><B>SOS LIMITED</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Name:&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Yandai Wang</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Title:</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Chief Executive Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTICE OF EXERCISE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TO: SOS LIMITED.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby
elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full),
and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take
the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said
Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Warrant Shares shall be delivered to the following DWAC
Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Investing Entity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Signature of Authorized Signatory of Investing Entity:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">______________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(To assign the foregoing Warrant,
execute this form and supply required information. Do not use this form to purchase shares.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced
thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt; text-align: justify">Name:</TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">(Please Print)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">Address:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">(Please Print)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">Phone Number:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">Email Address:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">Dated: _______________ __, ______</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">Holder&rsquo;s Signature:______________________</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">Holder&rsquo;s Address: ______________________</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">15</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>ea135490ex99-3_soslimited.htm
<DESCRIPTION>ENGAGEMENT LETTER DATED FEBRUARY 7, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-3_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">February 7, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VIA ELECTRONIC DELIVERY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Yandai Wang</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CEO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SOS Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Room 8888, Jiudingfeng Building, 888 Changbaishan Road,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Qingdao Area, China (Shandong) Pilot Free Trade Zone</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr. Wang:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are pleased that SOS Limited (collectively,
with its subsidiaries the &ldquo;Company&rdquo;) has decided to retain Maxim Group LLC (the &ldquo;<B>Financial Advisor</B>&rdquo;)
to provide general financial advisory and investment banking services to the Company as set forth herein. This letter agreement
(&ldquo;<B>Agreement</B>&rdquo;) will confirm the Financial Advisor&rsquo;s acceptance of such retention and set forth below are
the terms of our engagement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WHEREAS, the Company hereby retains the
Financial Advisor as its exclusive lead warrant solicitation agent in connection with its contemplated solicitation of the exercise
of the Company&rsquo;s Warrants (as defined below) for the period of time set forth herein, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WHEREAS, on January 20, 2021, the Company
issued warrants which will be exercisable into an aggregate of up to 23,880,000 ADSs, at an exercise price of $2.00 per ADS, to
certain investors (the &ldquo;<B>Warrants</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOW, THEREFORE, in consideration of the
premises and mutual agreements herein set forth, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.&nbsp;<U>Compliance
With Applicable Securities Laws/Best Efforts</U>. Each of the Company and the Financial Advisor agree that the Financial Advisor&rsquo;s
solicitation of Warrants shall be consistent with applicable federal and state securities laws, the guidelines of the Financial
Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;), applicable SEC rules and regulations, including but not limited to
Regulation M, the rules and regulations of the Nasdaq Capital Market Exchange and disclosure of the Company&rsquo;s compensation
arrangement with the Financial Advisor will be made in documents provided to the holders of the Warrants. Moreover, the Financial
Advisor shall, consistent with its obligations under applicable laws and the rules and regulations of FINRA, use its reasonable
best efforts to maximize the number of Warrants which are exercised, including appropriate communications with certain record owners
and beneficial owners of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. <U>Compensation.</U> The Company shall
pay to the Financial Advisor a cash fee consisting of a cash payment equal to seven percent (7.0%) of the total proceeds received
from the total net proceeds received from the exercise of any and all of the Warrants during the term of the Agreement or during
the Tail Period (as defined hereinafter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. <U>Timing of Payment.</U> Promptly following
receipt of the gross proceeds received by the Company from the cash exercise of the Warrants in accordance with this Agreement,
the Company shall pay the Solicitation Fee to the Financial Advisor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4. <U>Representation and Warranties of
the Company</U>. (a) The Company is a corporation duly organized, validly existing and in good standing under the laws of the Cayman
Islands and has full corporate power and authority to execute and deliver this Agreement and to consummate the transactions contemplated
hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Members FINRA &amp; SIPC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">405 Lexington Ave. * New York, NY 10174
* tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">SOS Limited.</P>

<P STYLE="text-align: right; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">February 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) The execution and delivery of this
Agreement and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by the board
of directors of the Company and the stockholders of the Company, if required, and no further consent or authorization is required
by the Company, the board of directors of the Company or of its stockholders. No other corporate proceedings on the part of the
Company are necessary to approve and authorize the execution and delivery of this Agreement. This Agreement constitutes the legal,
valid and binding agreement of the Company, enforceable against it in accordance with its terms, except as enforceability may be
limited by insolvency, bankruptcy or other similar laws affecting creditors&rsquo; rights generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) The Company&rsquo;s Registration Statements
(&ldquo;<B>Registration Statement</B>&rdquo;) on Form F-3 (File No. 333-250145), registering the resale of ADS issuable upon exercise
of the Warrants (the &ldquo;<B>Warrant Shares</B>&rdquo;) was declared effective by the Securities and Exchange Commission (the
&ldquo;<B>Commission</B>&rdquo;) on February 8, 2021 remains effective and shall remain effective during the term of this Agreement.
The Commission has not issued any orders preventing or suspending the use of the Prospectus contained in the Registration Statement
and the Prospectus (as modified or supplemented by information incorporated by reference into such Prospectus) as well as the Company&rsquo;s
other public filings (the &ldquo;<B>SEC filings</B>&rdquo;) conforms, and during the effectiveness of this Agreement will conform,
in all material respects with the requirements of the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;)
and the Securities Exchange Act of 1934 (the &ldquo;<B>Exchange Act</B>&rdquo;), as amended and do not, and during the effectiveness
of this Agreement will not, include any untrue statement of material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) The Warrant Shares have been duly authorized,
have been duly reserved for issuance and upon exercise of the Warrants and payment to the Company of the exercise price therefore,
the Warrant Shares will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(e) Neither the execution and delivery
of this Agreement by the Company nor the consummation of the transactions contemplated hereby will (i) conflict with or result
in any breach of any provisions of Memorandum and Articles of Association of the Company, each as amended to date; (ii) require
any consent, approval, authorization or permit from, or filing with or notification to, any United States or foreign governmental
or regulatory authority or other third party, except for any such consents approvals, authorizations, permits, filings or notifications,
the absence of which would not have a material adverse effect on the Company or the Warrants, (iii) result in a breach of the terms,
conditions or provisions of, constitute a default under or cause, permit or give rise to any right of termination, cancellation
or acceleration under any of the terms, conditions or provisions of any material agreement to which the Company is a party to.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.&nbsp;<U>Information</U>.
In connection with the Financial Advisor&rsquo;s activities hereunder, the Company will fully cooperate with the Financial Advisor
and furnish them upon request with all information regarding the business, operations, properties, financial condition, legal condition,
litigation status, management and prospects of the Company (all such information so furnished being the &ldquo;<B>Information</B>&rdquo;)
that the Financial Advisor deems appropriate for conducting their due diligence and will provide them with access to the Company&rsquo;s
officers, directors, employees, consultants, independent accountants and legal counsel. The Company represents and warrants to
the Financial Advisor that all Information made available to the Financial Advisor hereunder will be complete and correct in all
material respects and will not contain any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein not misleading in light of the circumstances under which such statements are or will be made. The
Company further represents and warrants that any projections and other forward-looking information provided by it to the Financial
Advisor will have been prepared in good faith and will be based upon assumptions (which shall be disclosed by the Company) which,
in light of the circumstances under which they are made, are reasonable. The Company recognizes and confirms that the Financial
Advisor: (i) will use and rely primarily on the Information and on information available from generally recognized public sources
in performing the services contemplated by this Agreement without having independently verified the same; (ii) does not assume
responsibility for the accuracy or completeness of the Information and such other information; and (iii) will not make an appraisal
of any assets of the Company. Any advice rendered by the Financial Advisor pursuant to this Agreement may not be disclosed publicly
without the Financial Advisor&rsquo;s prior written consent. The Financial Advisor hereby acknowledges that certain of the Information
received by the Financial Advisor may be confidential and/or proprietary, including Information with respect to the Company&rsquo;s
technologies, products, business plans, marketing, and other Information which must be maintained by the Financial Advisor as confidential.
The Financial Advisor agrees that it will not disclose such confidential and/or proprietary Information to any other companies
in the industry in which the Company is involved without the Company&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Members FINRA &amp; SIPC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">405 Lexington Ave. * New York, NY 10174
* tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">SOS Limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">February 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6.&nbsp;<U>Expenses</U>.
In addition to payment to the Financial Advisor of the compensation set forth in Section 2 hereof, the Company shall promptly upon
request from time to time reimburse the Financial Advisor for all reasonable expenses (including, without limitation, fees and
disbursements of counsel and all travel and other out-of-pocket expenses) incurred by the Financial Advisor in connection with
its engagement hereunder, in an amount not to exceed an aggregate of $10,000. In addition, the Company shall pay for all fees and
expenses, including the reasonable legal fees and expenses of counsel to the Financial Advisor, in connection with any filings
required by FINRA in connection with this Agreement. The Financial Advisor will provide the Company an invoice and copies of receipts
of its expenses and such expenses shall not exceed $5,000 without prior authorization of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">7.&nbsp;<U>Indemnification</U>.
The Company agrees to indemnify the Financial Advisor in accordance with the indemnification and other provisions attached to this
Agreement as <U>Exhibit A</U> (the &ldquo;<B>Indemnification Provisions</B>&rdquo;), which provisions are incorporated herein by
reference and shall survive the termination or expiration of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">8.&nbsp;<U>Other
Activities</U>. The Company acknowledges that the Financial Advisor has been, and may in the future be, engaged to provide services
as an underwriter, placement agent, finder, advisor and investment banker to other companies in the industry in which the Company
is or may be involved. Subject to the confidentiality provisions of the Financial Advisor contained in Section 5 hereof, the Company
acknowledges and agrees that nothing contained in this Agreement shall limit or restrict the right of the Financial Advisor or
of any past, present or future member, manager, partner, officer, director, owner, employee, agent or representative of or investor
in the Financial Advisor, to be a member, manager, partner, officer, director, owner, employee, agent or representative of, investor
in, or to engage in, any other business, whether or not of a similar, dissimilar or conflicting in nature to the Company&rsquo;s
business, nor to limit or restrict the right of the Financial Advisor and the foregoing persons and entities to render services
of any kind to any other corporation, firm, individual or association. The Financial Advisor may, but shall not be required to,
present opportunities to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">9.&nbsp;<U>Termination;
Survival of Provisions</U>. The Agreement shall become effective upon the date of mutual execution by both parties to this Agreement,
and shall continue to be in effect until the six months anniversary of this Agreement. Either the Company or the Financial Advisor
shall be entitled to terminate this Agreement prior to the exercise of all of the Warrants at any time after providing five (5)
business days prior notice to the other party. Notwithstanding any such termination, the Financial Advisor shall be entitled to
receive a Solicitation Fee for the exercise of any Warrant during the eighteen (18) month period following the termination of the
Agreement (the &ldquo;<B>Tail Period</B>&rdquo;). Notwithstanding anything expressed or implied herein to the contrary: the terms
and provisions of Sections 2, 3, 5, 6, 7, (including, but not limited to, the Indemnification Provisions attached to this Agreement
and incorporated herein by reference), this Section 9 through 17, shall survive the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Members FINRA &amp; SIPC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">405 Lexington Ave. * New York, NY 10174
* tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">SOS Limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">February 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">10.&nbsp;<U>Notices</U>.
All notices provided hereunder shall be given in writing and either delivered personally or by overnight courier service or sent
by certified mail, return receipt requested, or by facsimile transmission, if to the Financial Advisor, to Maxim Group LLC, 405
Lexington Avenue, 2<SUP>nd</SUP> Floor, New York, New York 10174, Attention: James Siegel, Esq., General Counsel, Fax No. (212)
895-3860, and if to the Company, to the address, set forth on the first page of this Agreement. Any notice delivered personally
or by fax shall be deemed given upon receipt (with confirmation of receipt required in the case of fax transmissions); any notice
given by overnight courier shall be deemed given on the next business day after delivery to the overnight courier; and any notice
given by certified mail shall be deemed given upon the second business day after certification thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">11.&nbsp;<U>Governing
Law; Venue; Jurisdiction; Waiver of Jury Trial</U>. This Agreement shall be governed by construed and enforced in accordance with
the laws of the State of New York applicable to agreements made and to be fully performed therein, without regard to conflicts
of law principles. The Company irrevocably agrees that any suit, claim, action or proceeding of any kind or nature whatsoever arising
out of this Agreement or any of the agreements, transactions or matters contemplated hereby, which is brought by or against the
Company shall be brought in the Supreme Court of the State of New York, County of New York or the United States District Court
for the Southern District of New York. The Company further irrevocably submits to the exclusive jurisdiction of the Supreme Court
of the State of New York, County of New York or the United States District Court for the Southern District of New York for the
purpose of any suit, claim, action or other proceeding of any kind or nature whatsoever arising out of this Agreement, or any of
the agreements , transactions or matters contemplated hereby, which is brought by or against the Company, and agrees that service
of process in connection with any such suit, claim, action or proceeding may be made upon the Company in accordance with Section
10 hereof it being agreed that such service shall be good and valid service to which the Company shall not challenge by way of
objection, defense or otherwise.. The parties hereby expressly waive all rights to trial by jury in any suit, claim, action or
proceeding arising under this Agreement, or any of the agreements, transactions or matters contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">12.&nbsp;<U>Amendments</U>.
This Agreement may not be modified or amended except in a writing duly executed by the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">13.&nbsp;<U>Headings</U>.
The section headings in this Agreement have been inserted as a matter of reference and are not part of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">14.&nbsp;<U>Successors
and Assigns</U>. The benefits of this Agreement shall inure to the parties hereto, their respective successors and assigns and
to the indemnified parties hereunder and their respective successors and assigns, and the obligations and liabilities assumed in
this Agreement shall be binding upon the parties hereto and their respective successors and assigns. Notwithstanding anything contained
herein to the contrary, neither the Financial Advisor nor the Company shall assign any of its obligations hereunder without the
prior written consent of the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">15.&nbsp;<U>No
Third Party Beneficiaries</U>. This Agreement does not create, and shall not be construed as creating, any rights enforceable by
any person or entity not a party hereto, except those entitled to the benefits of the Indemnification Provisions. Without limiting
the foregoing, the Company acknowledges and agrees that the Financial Advisor is not being engaged as, and shall not be deemed
to be, an agent or fiduciary of the Company&rsquo;s stockholders or creditors or any other person by virtue of this Agreement or
the retention of the Financial Advisor hereunder, all of which are hereby expressly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">16.&nbsp;<U>Waiver</U>.
Any waiver or any breach of any of the terms or conditions of this Agreement shall not operate as a waiver of any of the terms
or conditions of this Agreement or of any other breach of such terms or conditions or of any other term or condition, nor shall
any failure to insist upon strict performance or to enforce any provision hereof on any occasion operate as a waiver of such provision
or of any other provision hereof or a waiver of the right to insist upon strict performance or to enforce such provision or any
other provision on any subsequent occasion. Any waiver must be in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">17. <U>Counterparts</U>.
This Agreement may be executed in any number of counterparts and by facsimile transmission, each of which shall be deemed to be
an original instrument, but all of which taken together shall constitute one and the same agreement. Facsimile signatures shall
be deemed to be original signatures for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page and Exhibit A Follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Members FINRA &amp; SIPC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">405 Lexington Ave. * New York, NY 10174
* tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">SOS Limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">February 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing correctly
sets forth our agreement, please sign the enclosed copy of this Agreement in the space provided below and return it to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Best Regards,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>MAXIM GROUP LLC</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ Alex Jin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Alex Jin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Managing Director, Investment Banking</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ Clifford Teller</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Clifford Teller </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Executive Managing Director, Head of Investment Banking</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Agreed to and accepted this 7th day
of February 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">SOS Limited</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 4%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 36%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Yandai Wang</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Mr. Yandai Wang</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">CEO</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Members FINRA &amp; SIPC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">405 Lexington Ave. * New York, NY 10174
* tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">SOS Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">February 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEMNIFICATION PROVISIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Capitalized terms used
in this Exhibit shall have the meanings ascribed to such terms in the Agreement to which this Exhibit is attached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company agrees
to indemnify and hold harmless the Financial Advisor and each of the other Indemnified Parties (as hereinafter defined) from and
against any and all losses, claims, damages, obligations, penalties, judgments, awards, liabilities, attorneys fees, costs, expenses
and disbursements of any kind or nature whatsoever, and any and all actions, suits, proceedings and investigations of any kind
or nature whatsoever in respect thereof and any and all legal fees and other costs, expenses and disbursements in giving testimony
or furnishing documents in response to a subpoena or otherwise (including, without limitation, the legal fees, consulting or expert
fees, costs, expenses and disbursements, as and when incurred, of investigating, preparing, pursing or defending any such action,
suit, proceeding or investigation (whether or not in connection with litigation in which any Indemnified Party is a party)) (collectively,
&ldquo;<B>Losses</B>&rdquo;), directly or indirectly, caused by, relating to, based upon, arising out of, or in connection with,
the Financial Advisor&rsquo; acting for the Company, including, without limitation, any act or omission by the Financial Advisor
in connection with its acceptance of or the performance or non-performance of its obligations under the Agreement between the Company
and the Financial Advisor to which these indemnification provisions are attached and form a part (the &ldquo;<B>Agreement</B>&rdquo;),
any breach by the Company of any representation, warranty, covenant or agreement contained in the Agreement (or in any instrument,
document or agreement relating thereto, including any Agency Agreement), or the enforcement by the Financial Advisor of its rights
under the Agreement or these indemnification provisions, except to the extent that any such Losses are found in a final judgment
by a court of competent jurisdiction (not subject to further appeal) to have resulted primarily and directly from the gross negligence
or willful misconduct of the Indemnified Party seeking indemnification hereunder. The Company also agrees that no Indemnified Party
shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with
the engagement of the Financial Advisor by the Company or for any other reason, except to the extent that any such liability is
found in a final judgment by a court of competent jurisdiction (not subject to further appeal) to have resulted primarily and directly
from such Indemnified Party&rsquo;s gross negligence or willful misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These Indemnification
Provisions shall extend to the following persons (collectively, the &ldquo;<B>Indemnified Parties</B>&rdquo;): The Financial Advisor,
its present, former and future affiliated entities, managers, members, officers, directors, owners ,partners, stockholders, employees,
legal counsel, agents, representatives and controlling persons (within the meaning of the federal securities laws), and its and
their affiliated entities, managers, members, officers, directors, owners, partners, stockholders, employees, legal counsel, agents,
representatives and controlling persons of any of them. These indemnification provisions shall be in addition to any liability
which the Company may otherwise have to any Indemnified Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any action, suit,
proceeding or investigation is commenced, as to which an Indemnified Party proposes to demand indemnification, it shall notify
the Company with reasonable promptness; <U>provided</U>, <U>however</U>, that any failure by an Indemnified Party to notify the
Company shall not relieve the Company from its obligations hereunder. An Indemnified Party shall have the right to retain counsel
of its own choice to represent it, and the fees, expenses and disbursements of such counsel shall be borne by the Company. Any
such counsel shall, to the extent consistent with its professional responsibilities, cooperate with the Company and any counsel
designated by the Company. The Company shall be liable for and pay any settlement of any claim against any Indemnified Party made
with the Company&rsquo;s written consent. The Company shall not, without the prior written consent of the Financial Advisor, settle
or compromise any claim, or permit a default or consent to the entry of any judgment in respect thereof, unless such settlement,
compromise or consent (i) includes, as an unconditional term thereof, the giving by the claimant or claimants to all of the Indemnified
Parties of an unconditional release from all liability in respect of such claim, and (ii) does not contain any factual or legal
admission by or with respect to an Indemnified Party or an adverse statement with respect to the character, professionalism, expertise
or reputation of any Indemnified Party or any action or inaction of any Indemnified Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Members FINRA &amp; SIPC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">405 Lexington Ave. * New York, NY 10174
* tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">SOS Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">February 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to provide
for just and equitable contribution, if a claim for indemnification pursuant to these indemnification provisions is made but it
is found in a final judgment by a court of competent jurisdiction (not subject to further appeal) that such indemnification may
not be enforced in such case, even though the express provisions hereof provide for indemnification in such case, then the Company
shall contribute to the Losses to which any Indemnified Party may be subject (i) in accordance with the relative benefits received
by the Company and its stockholders, subsidiaries and affiliates, on the one hand, and the Indemnified Party, on the other hand,
and (ii) if (and only if) the allocation provided in clause (i) of this sentence is not permitted by applicable law, in such proportion
as to reflect not only the relative benefits, but also the relative fault of the Company, on the one hand, and the Indemnified
Party, on the other hand, in connection with the statements, acts or omissions which resulted in such Losses as well as any relevant
equitable considerations. No person found liable for a fraudulent misrepresentation shall be entitled to contribution from any
person who is not also found liable for fraudulent misrepresentation. The relative benefits received (or anticipated to be received)
by the Company and its stockholders, subsidiaries and affiliates shall be deemed to be equal to the aggregate consideration payable
or receivable by such parties in connection with the transaction or transactions to which the Agreement relates relative to the
amount of fees actually received by the Financial Advisor in connection with such transaction or transactions. Notwithstanding
the foregoing, in no event shall the amount contributed by all Indemnified Parties exceed the amount of fees previously received
by the Financial Advisor pursuant to the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither termination
nor completion of the Agreement shall affect these Indemnification Provisions which shall remain operative and in full force and
effect. The Indemnification Provisions shall be binding upon the Company and its successors and assigns and shall inure to the
benefit of the Indemnified Parties and their respective successors, assigns, heirs and personal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company shall be
required to advance to the Indemnified Parties all legal fees, consultant and expert fees, costs, disbursements and other expenses
relating to, associated with or arising from the Losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Members FINRA &amp; SIPC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">405 Lexington Ave. * New York, NY 10174
* tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">7</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>ea135490ex99-4_soslimited.htm
<DESCRIPTION>PRESS RELEASE DATED FEBRUARY 9, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SOS Limited Announces Exercise of Warrants for Approximately
$48 Million in Gross Proceeds</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">QINGDAO, China,&nbsp;Feb. 9, 2021&nbsp;/PRNewswire/ -- SOS Limited
(NYSE:&nbsp;SOS) (the &ldquo;Company&rdquo; or &ldquo;SOS&rdquo;) today announced the agreement by several accredited investors
to exercise certain warrants to purchase up to an aggregate of 23,880,000&nbsp;of its American Depositary Shares (&ldquo;ADSs&rdquo;)
issued by the company on&nbsp;January 20, 2021, at an exercise price of&nbsp;$2.00.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The ADSs issuable upon exercise of the warrants are registered
pursuant to a registration statement on Form F-3 (File No. 333-252279) which became effective by the Securities and Exchange Commission
(SEC) on&nbsp;February 8, 2021. The gross proceeds to the company from the exercise of the warrants are expected to be approximately
$48&nbsp;million, prior to deducting placement agent fees and estimated offering expenses.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maxim Group LLC is acting as the exclusive financial advisor
for the offering.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In consideration for the immediate exercise of the warrants
for cash, the exercising holders will receive new unregistered warrants to purchase ADSs in a private placement pursuant to Section
4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;1933 Act&rdquo;). The warrants will be exercisable into an aggregate
of up to 23,880,000 ADSs, at an exercise price of&nbsp;$4.05&nbsp;per ADS, which have a term of exercise approximately equal to
five years.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SOS intends to use the proceeds from the offering to develop
its planned blockchain-based cryptocurrency mining and security and insurance technology business and acquisition in the cryptocurrency
industry as well as for working capital and general corporate use.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The new warrants described above were offered in a private placement
pursuant to an applicable exemption from the registration requirements of the 1933 Act and, along with the ADSs issuable upon their
exercise, have not been registered under the 1933 Act, and may not be offered or sold in&nbsp;the United States&nbsp;absent registration
with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors.
The company has agreed to file a registration statement with the SEC covering the resale of the ADSs issuable upon exercise of
the new warrants.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release shall not constitute an offer to sell or
a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or
jurisdiction.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About SOS Limited</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SOS Limited, through its operating subsidiary, SOS Information
Technology Co., Ltd. (&ldquo;SOS&rdquo;) is a high-technology company providing a wide range of services to its corporate and individual
members, including marketing data, technology and solutions for emergency rescue services. SOS transforms digital technology into
data-driven operations through the research and development of big data, cloud computing, Internet of Things, blockchain and artificial
intelligence.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have created a SOS cloud emergency rescue service software
as a service (SaaS) platform with three major product categories: basic cloud, cooperative cloud, and information. This system
provides innovative marketing solutions to clients such as insurance companies, financial institutions, medical institutions, healthcare
providers, auto manufacturers, security providers, senior living assistance providers, and other service providers in the emergency
rescue services industry.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SOS has obtained a national high-tech enterprise certification
and the title of &ldquo;big data star enterprise,&rdquo; awarded by Gui&rsquo;an New District Government. Staying on the forefront
of digital technology innovation, the Company has registered 32 software copyrights and 2 patents. For more information, please
visit:&nbsp;http://www.sosyun.com/</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain statements made herein are &ldquo;forward-looking statements&rdquo;
within the meaning of the &ldquo;safe harbor&rdquo; provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements may be identified by the use of words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;plan,&rdquo; &ldquo;outlook,&rdquo; and &ldquo;project&rdquo; and other similar expressions that
predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include
timing of the proposed transaction; the business plans, objectives, expectations and intentions of the parties;, SOS&rsquo;s estimated
and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities
market acceptance of our products; the ultimate impact of the current Coronavirus pandemic, or any other health epidemic, on our
business, our research programs, healthcare systems or the global economy as a whole; our intellectual property; our reliance on
third party organizations; our anticipated financial and operating results, including anticipated sources of revenues; our assumptions
regarding the size of the available market, benefits of our product offering, product pricing, timing of product launches; management&rsquo;s
expectation with respect to future acquisitions; statements regarding our goals, intentions, plans and expectations, including
the introduction of new products and markets; and our cash needs and financing plans and etc. These forward-looking statements
reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must
be exercised in relying on forward-looking statements. SOS may not realize its expectations, and its beliefs may not prove correct.
Due to known and unknown risks, our actual results may differ materially from our expectations or projections. All forward-looking
statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors.
Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additional information concerning these
and other factors that may impact our expectations and projections can be found in our periodic filings with the SEC, including
our Annual Report on Form 20-F for the fiscal year ended&nbsp;December 31, 2019. SOS&rsquo;s SEC filings are available publicly
on the SEC&rsquo;s website at&nbsp;www.sec.gov. SOS disclaims any obligation to update the forward-looking statements, whether
as a result of new information, future events or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SOURCE SOS Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex99-3_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Z .L# 2(  A$! Q$!_\0
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M<*BI2M&?5E6-EF&$AB93H/GWA1Y[TI*_-"ISR=Y;-625GI?I^:'Q(_X+(_\
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M7@X:..KYW2HQS/%0ISH4\:H<TW'E=.G5E15-U)T[<K:NTXZMI;7_ &6^(?\
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M\XM>1G6;1RG#1J1@JM:I+EITVVDXJW/.5M5&*:2>W,_(_P!)0_\ !=C_ ()
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M7XJ_X+Q?\%H_B_\ \%._C+H6H-^RK^R=XBT*/X(>$-?B,FF_VKX>FO9OV>?
M)M96-L]UX9M6U#X^_$>"U,T,'C_6M!M+N%M,U^*-?J#_ (.3?^"F:?&+X'_L
MQ?\ !/7]B'76^)_CC_@H9I7PR^(>IS>"IS->Z]\$?'^JV"?![P1:&(K/:7?Q
MN\8M;3:A;3FWGM/!WA/6++6($T[Q("?Z.O\ @F#^PEX/_P""<G[%GP>_9?\
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M+GQVO+NZNY4AB:63X9^);2PLT9V56NM2U&XM--L80P>XO;NWMX\R2J#^-/\
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M4:%H/C"S6'Q#H^C>)&TG2FU_2]/U&WL=8;3-/.HP7!LK;ROY-O\ AH'X]?\
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@H8JK&/LZCH2M*-&%G4HRC4<5]4;5-R5-.HVH<R;?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
